Pay in 4 interest-free payments of $6.87 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Patients who see the best results treat GHK-Cu as a non-negotiable part of their daily evening routine, not as an optional treatment
Cagrilintide monotherapy at 4.5 mg weekly achieved 10.8% average weight loss over 26 weeks versus 3% with placebo in its Phase 2 dose-finding trial
Reduce the risk of heart-related events, such as strokes, heart attacks, or death, in adults with type 2 diabetes who have known heart disease
Aurapeptide.eu does not provide medical advice, dosing guidance, administration information, or preparation instructions
US$ 23.59
US$ 29.00
US$ 22.94
US$ 27.45
US$ 29.53
US$ 23.76
US$ 29.09
